Cargando…

NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies

NK cells play a key role in immune response against HIV infection. These cells can destroy infected cells and contribute to adequate and strong adaptive immune responses, by acting on dendritic, T, B, and even epithelial cells. Increased NK cell activity reflected by higher cytotoxic capacity, IFN-γ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flórez-Álvarez, Lizdany, Hernandez, Juan C., Zapata, Wildeman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199347/ https://www.ncbi.nlm.nih.gov/pubmed/30386329 http://dx.doi.org/10.3389/fimmu.2018.02290

Ejemplares similares

NK Cell Activity and CD57(+)/NKG2C(high) Phenotype Are Increased in Men Who Have Sex With Men at High Risk for HIV
por: Flórez-Álvarez, Lizdany, et al.
Publicado: (2020)

NK cells from Men Who Have Sex with Men at high risk for HIV-1 infection exhibit higher effector capacity
por: Rincón, Daniel S., et al.
Publicado: (2023)

Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia
por: Zapata-Cardona, María I., et al.
Publicado: (2022)

Seronegative MSM at high risk of HIV-1 acquisition show an immune quiescent profile with a normal immune response against common antigens
por: Ossa-Giraldo, Ana C., et al.
Publicado: (2022)

Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months
por: Lopera, Tulio J., et al.
Publicado: (2022)

Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms
por: Marín-Palma, Damariz, et al.
Publicado: (2021)

Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro
por: Zapata-Cardona, María I., et al.
Publicado: (2022)

The Hydroalcoholic Extract of Uncaria tomentosa (Cat's Claw) Inhibits the Infection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) In Vitro
por: Yepes-Perez, Andres F., et al.
Publicado: (2021)

Comparison among plaque assay, tissue culture infectious dose (TCID(50)) and real-time RT-PCR for SARS-CoV-2 variants quantification
por: Zapata-Cardona, Maria Isabel, et al.
Publicado: (2022)

In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach
por: Zapata-Cardona, Maria I., et al.
Publicado: (2023)

Changes in NK Cell Subsets and Receptor Expressions in HIV-1 Infected Chronic Patients and HIV Controllers
por: Zhang, Zhi, et al.
Publicado: (2021)

Cytokine-Induced Memory-Like NK Cells: From the Basics to Clinical Applications
por: Terrén, Iñigo, et al.
Publicado: (2022)

Targeting NK Cells for HIV-1 Treatment and Reservoir Clearance
por: Duan, Siqin, et al.
Publicado: (2022)

Editorial: Syphilis infection: clinical, epidemiology, basic science, and behavioral research
por: Zhou, Pingyu, et al.
Publicado: (2023)

PM10 promotes an inflammatory cytokine response that may impact SARS-CoV-2 replication in vitro
por: Marín-Palma, Damariz, et al.
Publicado: (2023)

Genetic and Immunological Factors Involved in Natural Resistance to HIV-1 Infection
por: Taborda-Vanegas, Natalia, et al.
Publicado: (2011)

SM-COLSARSPROT: Highly Immunogenic Supramutational Synthetic Peptides Covering the World’s Population
por: Patarroyo, Manuel A., et al.
Publicado: (2022)

Evaluation of Functional NK Cell Responses in Vaccinated and SIV-Infected Rhesus Macaques
por: Vargas-Inchaustegui, Diego A., et al.
Publicado: (2016)

Immune characterization of a Colombian family cluster with SARS-CoV-2 infection
por: Aguilar-Jiménez, Wbeimar, et al.
Publicado: (2021)

NK cells and poxvirus infection
por: Burshtyn, Deborah N.
Publicado: (2013)

Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV
por: Marras, Francesco, et al.
Publicado: (2014)

Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
por: Bödder, Johanna, et al.
Publicado: (2021)

NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune Responses
por: Mensching, Leonore, et al.
Publicado: (2022)

The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life
por: Slyker, Jennifer A., et al.
Publicado: (2012)

Analysis of the Characteristics of TIGIT-Expressing CD3(−)CD56(+)NK Cells in Controlling Different Stages of HIV-1 Infection
por: Zhang, Xin, et al.
Publicado: (2021)

A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART
por: Gondois-Rey, Françoise, et al.
Publicado: (2017)

Monkeying Around: Using Non-human Primate Models to Study NK Cell Biology in HIV Infections
por: Manickam, Cordelia, et al.
Publicado: (2019)

CD56-negative NK cells: Frequency in peripheral blood, expansion during HIV-1 infection, functional capacity, and KIR expression
por: Cocker, Alexander T. H., et al.
Publicado: (2022)

Metabolism of NK cells during viral infections
por: Osuna-Espinoza, Kenia Y., et al.
Publicado: (2023)

Immune Dysfunctions of CD56(neg) NK Cells Are Associated With HIV-1 Disease Progression
por: Cao, Wen-Jing, et al.
Publicado: (2022)

Bet on NETs! Or on How to Translate Basic Science into Clinical Practice
por: Ramirez, Giuseppe A., et al.
Publicado: (2016)

Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy
por: Tarannum, Mubin, et al.
Publicado: (2022)

Recent Advances in Lentiviral Vaccines for HIV-1 Infection
por: Norton, Thomas D., et al.
Publicado: (2016)

A Natural Impact: NK Cells at the Intersection of Cancer and HIV Disease
por: Lucar, Olivier, et al.
Publicado: (2019)

Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity
por: Bernard, Nicole F., et al.
Publicado: (2017)

Subordinate Effect of -21M HLA-B Dimorphism on NK Cell Repertoire Diversity and Function in HIV-1 Infected Individuals of African Origin
por: Cubero, Elia Moreno, et al.
Publicado: (2020)

Mucosal Vaccination Primes NK Cell-Dependent Development of CD8(+) T Cells Against Pulmonary Brucella Infection
por: Bhagyaraj, Ella, et al.
Publicado: (2021)

Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity
por: Chretien, Anne-Sophie, et al.
Publicado: (2014)

Prospects for NK-based immunotherapy of chronic HBV infection
por: Jin, Xiaomeng, et al.
Publicado: (2022)

S100A9 Tetramers, Which are Ligands of CD85j, Increase the Ability of MVA(HIV)-Primed NK Cells to Control HIV Infection
por: Moreno-Nieves, Uriel Y., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cc16gg0bmd8mlhuuehjhtnn72o